IL117076A0 - Compounds having growth hormone releasing properties pharmaceutical compositions containing them and their use - Google Patents

Compounds having growth hormone releasing properties pharmaceutical compositions containing them and their use

Info

Publication number
IL117076A0
IL117076A0 IL11707696A IL11707696A IL117076A0 IL 117076 A0 IL117076 A0 IL 117076A0 IL 11707696 A IL11707696 A IL 11707696A IL 11707696 A IL11707696 A IL 11707696A IL 117076 A0 IL117076 A0 IL 117076A0
Authority
IL
Israel
Prior art keywords
compounds
pharmaceutical compositions
compositions containing
growth hormone
hormone releasing
Prior art date
Application number
IL11707696A
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL117076A0 publication Critical patent/IL117076A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
IL11707696A 1995-02-09 1996-02-08 Compounds having growth hormone releasing properties pharmaceutical compositions containing them and their use IL117076A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK14795 1995-02-09

Publications (1)

Publication Number Publication Date
IL117076A0 true IL117076A0 (en) 1996-06-18

Family

ID=8090300

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11707696A IL117076A0 (en) 1995-02-09 1996-02-08 Compounds having growth hormone releasing properties pharmaceutical compositions containing them and their use

Country Status (4)

Country Link
AU (1) AU4534696A (en)
IL (1) IL117076A0 (en)
WO (1) WO1996024587A1 (en)
ZA (1) ZA961008B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
US6605623B1 (en) 1998-12-18 2003-08-12 Bristol-Myers Squibb Pharma Co. N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
CA2362290A1 (en) 1999-02-18 2000-08-24 Kaken Pharmaceutical Co., Ltd. Novel amide derivatives as growth hormone secretagogues
ATE446758T1 (en) 2000-05-31 2009-11-15 Pfizer Prod Inc USE OF GROWTH HORMONE SECRETAGOGENES TO PROMOTE DIGESTIVE MOTILITY
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (en) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
EP2118080B1 (en) 2007-02-09 2016-08-31 Ocera Therapeutics, Inc. Macrocyclic ghrelin receptor modulators and methods of using the same
CN103313968A (en) 2010-11-15 2013-09-18 Abbvie公司 Nampt and rock inhibitors
WO2013190520A2 (en) 2012-06-22 2013-12-27 The General Hospital Corporation Gh-releasing agents in the treatment of vascular stenosis and associated conditions
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
WO2017075535A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Also Published As

Publication number Publication date
AU4534696A (en) 1996-08-27
WO1996024587A1 (en) 1996-08-15
ZA961008B (en) 1996-08-29

Similar Documents

Publication Publication Date Title
IL116923A0 (en) Compounds with growth hormone releasing properties and pharmaceutical compositions containing them
IL121621A0 (en) Neurotrophic compounds pharmaceutical compositions containing them and their use
IL122618A0 (en) Substituted imidazolylacetonitrile compounds their preparation and pharmaceutical compositions containing them
IL117860A0 (en) Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them
IL119078A (en) Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them
IL113389A0 (en) 1,4-Benzodiazepine compounds, pharmaceutical compositions containing them, their preparation and use
IL116775A (en) Tricyclic azolobenzodiazepines and similar compounds their preparation and pharmaceutical compositions containing them
IL121236A0 (en) Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
IL105220A0 (en) Cyclohexanylidene compounds and pharmaceutical compositions containing them
IL114622A0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
IL122293A0 (en) Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them
AP9701160A0 (en) Compounds and pharmaceutical compositions containing them
IL119559A0 (en) Purin -6- one derivatives their preparation and pharmaceutical compositions containing them
IL115905A0 (en) Sordarin derivatives their preparation and pharmaceutical compositions containing them
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
IL117981A0 (en) Compositions containing 2-oxetanones their preparation and use
IL117075A0 (en) Compounds having growth hormone releasing properties pharmaceutical compositions containing them and their use
IL117815A0 (en) Ascomycins their preparation and pharmaceutical compositions containing them
IL108073A0 (en) Substituted 6-azaandrostenones their preparation and pharmaceutical compositions containing them
IL113366A0 (en) 1,5-benzodiazepine compounds, their preparation and use, and pharmaceutical compositions containing them
IL117076A0 (en) Compounds having growth hormone releasing properties pharmaceutical compositions containing them and their use
IL114623A0 (en) Substituted triazolylmethylphenylnaph-thyridones their preparation and pharmaceutical compositions containing them
IL118672A0 (en) Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
IL119371A0 (en) Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them
IL107611A0 (en) Steroid compounds and pharmaceutical compositions containing them